학술논문
Effects of Trilaciclib on Chemotherapy-Induced Myelosuppression and Patient-Reported Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer: Pooled Results from Three Phase II Randomized, Double-Blind, Placebo-Controlled Studies
Document Type
Article
Author
Source
In Clinical Lung Cancer September 2021 22(5):449-460
Subject
Language
ISSN
1525-7304